1. Abeloff MD, Slavik M, Luk GD, Griffin CA, Hermann J, Blanc O, Sjoerdsma A, Baylin SB (1984) Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine. An inhibitor of polyamine synthesis. J Clin Oncol 2: 124–130
2. Ajani JA, Ota DM, Grossie VB, Levin B, Nishioka K (1989) Alterations in polyamine metabolism during continuous intravenous infusion of alpha-difluoromethylornithine: correlation of thrombocytopenia with alpha-difluoromethylornithine plasma levels. Cancer Res 49: 5761–5765
3. Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH (1989) Comprehensive criteria for therapy-induced toxicity. Cancer Invest 8: 141–153
4. Bjerkvig R, Oredsson SM, Marton LJ, Linden M, Deen DF (1983) Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithine. Cancer Res 43: 1497–1500
5. Ducore JM, McNamara L (1986) Effect of alpha-difluoromethylornithine onl-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro. Cancer Res 46: 1068–1072